Apellis Pharmaceuticals Income Statement (2020-2025) | APLS

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue -3.92M-6.91M0.65M250.00M-4.17M0.62M5.65M60.29M14.38M16.32M22.06M22.66M44.85M94.97M110.40M146.38M172.32M199.69M196.83M212.53M166.80M178.49M458.58M
Cost of Revenue 0.15M0.05M1.25M0.08M1.38M2.92M7.81M8.38M22.41M19.91M20.21M23.10M33.56M40.86M34.36M13.63M24.53M
Gross Profit 5.50M60.24M13.13M16.24M20.68M19.74M37.04M86.59M87.99M126.47M152.12M176.59M163.27M171.67M132.44M164.87M434.05M
Operating items
Research & Development 69.28M87.09M93.21M50.34M84.01M95.94M87.73M78.18M90.94M101.66M95.21M99.42M110.03M95.66M79.42M69.28M84.70M77.95M88.57M76.35M86.42M67.02M68.19M
Selling, General & Administrative 29.50M28.41M36.99M44.49M40.58M48.97M45.76M41.46M51.19M63.20M78.41M84.37M102.09M111.37M145.65M141.70M129.50M128.08M121.98M121.48M129.34M131.14M142.68M
Other Operating Expenses -16.72M25.05M50.00M0.15M30.05M1.25M0.08M1.38M2.92M7.81M8.38M22.41M19.91M20.21M23.10M33.56M40.86M34.36M13.63M24.53M
Operating Expenses 98.79M98.79M130.20M119.88M124.59M194.91M133.65M149.69M143.38M164.95M174.99M186.72M219.93M215.41M247.48M230.90M234.41M229.13M244.11M238.69M250.12M211.78M235.40M
Operating Income -98.79M-115.51M-129.55M130.12M-124.59M-194.29M-128.00M-89.40M-129.00M-148.62M-152.94M-164.05M-175.08M-120.44M-137.08M-84.52M-62.09M-29.44M-47.28M-26.16M-83.33M-33.29M223.18M
EBIT -98.79M-115.51M-129.55M130.12M-124.59M-194.29M-128.00M-89.40M-129.00M-148.62M-152.94M-164.05M-175.08M-120.44M-137.08M-84.52M-62.09M-29.44M-47.28M-26.16M-83.33M-33.29M223.18M
Non-operating items
Interest & Investment Income 2.27M1.02M0.67M0.19M0.13M0.10M0.14M0.04M0.10M1.43M2.81M4.58M5.39M6.00M4.99M4.55M3.30M3.18M2.89M3.40M2.66M2.61M4.38M
Other Non Operating Income -68.41M2.77M2.70M-40.09M-17.10M-21.18M-4.22M-55.17M-0.29M0.15M0.10M-0.25M-0.28M-0.06M-0.60M0.22M-0.50M0.02M0.07M-1.76M-0.17M0.15M0.04M
Non Operating Income 0.01M0.01M-0.02M22.76M1.54M-0.06M-0.12M37.31M-0.29M0.15M0.10M50.26M-0.28M-0.06M-0.60M43.05M-0.50M0.02M0.07M17.20M-0.17M0.15M0.04M
Net income details
EBT -100.43M-121.39M-138.38M120.70M-183.66M-219.19M-195.57M-147.58M-137.73M-155.49M-190.82M-167.46M-177.50M-121.84M-140.00M-87.15M-66.25M-37.54M-56.85M-36.07M-91.88M-41.69M216.32M
Tax Provisions 0.35M1.21M0.49M0.45M-1.47M0.30M0.20M0.23M1.42M0.20M0.11M0.60M0.26M0.34M0.50M0.60M
Profit After Tax -168.82M-118.62M-135.70M78.27M-183.66M-219.19M-195.57M-147.93M-138.94M-155.98M-191.27M-165.99M-177.78M-122.04M-140.24M-88.58M-66.42M-37.66M-57.45M-36.35M-92.22M-42.15M215.72M
Income from Continuing Operations -100.43M-121.39M-138.38M120.70M-183.66M-219.19M-195.57M-147.93M-138.94M-155.98M-191.27M-165.99M-177.80M-122.04M-140.24M-88.58M-66.45M-37.66M-57.45M-36.33M-92.22M-42.19M215.72M
Consolidated Net Income -100.43M-121.39M-138.38M120.70M-183.66M-219.19M-195.57M-147.93M-138.94M-155.98M-191.27M-165.99M-177.80M-122.04M-140.24M-88.58M-66.45M-37.66M-57.45M-36.33M-92.22M-42.19M215.72M
Income towards Parent Company -100.43M-121.39M-138.38M120.70M-183.66M-219.19M-195.57M-147.93M-138.94M-155.98M-191.27M-165.99M-177.80M-122.04M-140.24M-88.58M-66.45M-37.66M-57.45M-36.33M-92.22M-42.19M215.72M
Net Income towards Common Stockholders -100.43M-121.39M-138.38M120.70M-183.66M-219.19M-195.57M-147.93M-138.94M-155.98M-191.27M-165.99M-177.80M-122.04M-140.24M-88.58M-66.45M-37.66M-57.45M-36.33M-92.22M-42.19M215.72M
Additional items
EPS (Basic) -2.29-1.57-1.791.03-2.32-2.72-2.28-1.53-1.42-1.46-1.75-1.50-1.56-1.02-1.17-0.72-0.54-0.30-0.46-0.29-0.74-0.331.71
EPS (Weighted Average and Diluted) 1.61-2.32-2.28-1.53-1.42-1.46-1.75-1.50-1.56-1.02-1.17-0.72-0.54-0.30-0.46-0.29-0.74-0.331.67
Shares Outstanding (Weighted Average) 75.32M75.51M75.60M75.74M80.38M80.50M87.00M87.30M97.73M106.52M109.87M110.58M111.29M116.46M117.74M118.50M120.58M121.37M121.77M124.39M125.52M125.68M126.29M
Shares Outstanding (Diluted Average) 75.16M0.08M0.09M84.42M0.10M0.11M0.11M106.11M0.11M119.32M120.29M118.68M122.96M123.90M124.23M123.91M125.45M126.02M
EBITDA -167.66M-119.30M-137.79M79.91M-185.16M-219.40M-195.75M-148.01M-138.90M-157.11M-191.10M-163.84M-177.68M-122.06M-140.51M-91.05M-66.41M-37.49M-57.22M-36.52M-91.97M-41.67M215.88M
Interest Expenses 3.92M6.91M9.50M9.61M4.17M3.77M2.28M3.02M8.54M8.45M7.90M7.74M7.53M7.34M7.31M7.40M6.97M9.36M12.53M11.53M11.05M11.15M11.28M
Tax Rate 0.88%0.28%